Second Inhaler Company Caps Prices at $35 a Month After Baldwin's Investigation into High Costs
March 18, 2024
March 18, 2024
WASHINGTON, March 19 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release on March 18, 2024:
Today, AstraZeneca joined Boehringer Ingelheim as the second inhaler manufacturer to announce they are capping the out-of-pocket cost for their inhaler products at $35 per month in the United States. This news comes after Senator Baldwin and her colleagues launched an investigation into the high costs Americans pay for inhalers, demanding answers from the four biggest inhale . . .
Today, AstraZeneca joined Boehringer Ingelheim as the second inhaler manufacturer to announce they are capping the out-of-pocket cost for their inhaler products at $35 per month in the United States. This news comes after Senator Baldwin and her colleagues launched an investigation into the high costs Americans pay for inhalers, demanding answers from the four biggest inhale . . .